About Us
Milestones
Current
-Recombinant Antibody
-Biologically active antibodies
-Development of nanobody
2023
-Collaborate with BioLASCO Taiwan Co., Ltd. in the direction of histology and pathology
2022
- Pathology validated antibody
2021
- ISO13485:2016 Certified.
- Diagnostic Regents for CTC & Bio-chip
2020
- Distribution & Co-brand
2019
- Antibody Production & Animal Facilities
2018
- iReal Biotechnology Established in Hsinchu,TW